Skip to main content
Global Edition
Thursday, May 2, 2024

Health Headlines - 4-17-20

Credit: FOX 47 News Michigan
Duration: 02:15s 0 shares 1 views

Health Headlines - 4-17-20
Health Headlines - 4-17-20

In today's health headlines we talk about a drug originally made for Ebola could work for COVID-19.

Also, more people have stocked up on prescriptions once the pandemic hit.

COULD A DRUG ORIGINALLY MADE TOTREAT EBOLA... BECOME THE FIRSTF-D-AAPPROVED TREATMENT FOR COVID-19?EARLY DATA SHOWS... IT COULD BEEFFECTIVE.SARAH DALLOF HAS THE DETAILS.IT'S TOO EARLY TO CALL IT A SURECURE...NATS STOCK BELLBUT STOCKS OF PHARMACEUTICALCOMPANY GILEAD SURGED..

ON A NEWREPORT ABOUT A TRIAL OFREMDESIVIR SHOWING PROMISING,BUT ALSO VERY PRELIMINARYRESULTS.ACCORDING TO MEDICAL NEWSWEBSITE "STAT"... WHICH OBTAINEDVIDEO OF A DISCUSSION ABOUT THETRIAL... THE UNIVERSITY OFCHICAGO MEDICINE TREATED 125PATIENTS- THE MAJORITY OF WHOMWERE SERIOUSLYILL- WITH DAILY INFUSIONS OFREMDESIVIR.TWO DIED... BUT MOST RECOVEREDSO WELL THEY WERE DISCHARGED.IN A STATEMENT... THE UNIVERSITYSAID IN PART THAT DRAWINGCONCLUSIONS FROMPARTIAL DATA, WOULD BE"PREMATURE AND SCIENTIFICALLYUNSOUND"LAST FRIDAY..

RESEARCH PUBLISHEDIN THE NEW ENGLAND JOURNAL OFMEDICINE FOUND 68PERCENT OF PATIENTS IN A SMALLERSTUDY WERE ABLE TO REDUCE OXYGENSUPPORT- INCLUDING THEUSE OF VENTILATORS- AFTERRECEIVING REMDESIVIR.INFECTIONS DISEASE EXPERTS ARECAUTIOUSLY OPTIMISTIC ... BUTSAY MORE DATA IS NEEDED...INCLUDINGFROM TRIALS WHERE SOME PATIENTSRECEIVE THE DRUG..

AND OTHERSARE GIVEN A PLACEBO.S/ DR. ADARSH BHIMRAJ/ CLEVELANDCLINIC"IT LOOKS VERY ENCOURAGINGCOMPARED TO A LOT OF OTHERMEDICATIONS AND BASED ONWHATEVER'S PUBLISHED SO FAR BUTWE STILL NEED INFO FROM THERANDOMIZED CONTROLLED TRIAL ANDI'MOPTIMISTIC WE'LL HAVE THATINFORMATION PRETTY SOON."LEAVING RESEARCHERS AND HEALTHEXPERTS IN A ONGOING SEARCH..FOR A COVID-19 TREATMENTBREAKTHROUGH.THERE HAVE BEEN NUMEROUS STUDIESON THE DRUG.ONE OF THE BIGGEST -- ISCURRENTLY UNDERWAY AT EMORYUNIVERSITY HOSPITAL INATLANTA.IT'S A DOUBLE-BLIND STUDY...WHERE NEITHER THE DOCTOR NOR THEPATIENT KNOWIF THEY'RE BEING GIVEN THEDRUG... OR A PLACEBO.MORE PEOPLE STARTED STOCKING UPON PRESCRIPTION MEDICATIONS...WHENTHE CORONAVIRUS OUTBREAK IN THEU-S BEGAN.RESEARCHERS FOUND...PRESCRIPTIONS FOR DEPRESSION...ANXIETY... AND INSOMNIAWENT UP 21 PERCENT... BETWEENFEBRUARY AND MARCH.ANTI-ANXIETY DRUGS HAD THELARGEST JUMP WITH 34 PERCENT.ANTI-DEPRESSANTS ROSE 18PERCENT.AND ANTI-INSOMNIA WENT UP 15PERCENT.THE FIGURES PEAKED THE WEEK OFMARCH 15TH... WHEN THE U-SDECLARED A NATIONALEMERGENCY... AND THE W-H-O

You might like

Related news coverage

Advertisement

More coverage

Days feeling the same

KTNV Channel 13 Las Vegas

It may feel like all the days are meshing together, and experts say that our cognitive health is being impacted. Not having our..